Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure

Background. Interleukin-11 (IL-11) is an important inflammatory cytokine and has been demonstrated to participate in cardiovascular diseases. However, there have been no studies about the role of IL-11 in heart failure (HF). The present study is aimed at investigating whether IL-11 levels are associ...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Ye, Zhen Wang, Di Ye, Yuan Wang, Menglong Wang, Qingwei Ji, Ying Huang, Ling Liu, Ying Shi, Lei Shi, Tao Zeng, Yao Xu, Jianfang Liu, Huimin Jiang, Yingzhong Lin, Jun Wan
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/1575410
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554685864607744
author Jing Ye
Zhen Wang
Di Ye
Yuan Wang
Menglong Wang
Qingwei Ji
Ying Huang
Ling Liu
Ying Shi
Lei Shi
Tao Zeng
Yao Xu
Jianfang Liu
Huimin Jiang
Yingzhong Lin
Jun Wan
author_facet Jing Ye
Zhen Wang
Di Ye
Yuan Wang
Menglong Wang
Qingwei Ji
Ying Huang
Ling Liu
Ying Shi
Lei Shi
Tao Zeng
Yao Xu
Jianfang Liu
Huimin Jiang
Yingzhong Lin
Jun Wan
author_sort Jing Ye
collection DOAJ
description Background. Interleukin-11 (IL-11) is an important inflammatory cytokine and has been demonstrated to participate in cardiovascular diseases. However, there have been no studies about the role of IL-11 in heart failure (HF). The present study is aimed at investigating whether IL-11 levels are associated with the cardiac prognosis in patients with HF. Methods. The plasma concentrations of IL-11 were measured in 240 patients with chronic HF (CHF) and 80 control subjects without signs of significant heart disease. In addition, we prospectively followed these CHF patients to endpoints of cardiac events. Results. Compared with the control group, the plasma IL-11 concentrations were significantly increased in the CHF patients and gradually increased in the New York Heart Association (NYHA) functional class II group, the NYHA functional class III group, and the NYHA functional class IV group. The receiver operating characteristic (ROC) curve revealed that the predictive role of IL-11 in HF is not as good as N-terminal B-type natriuretic peptide (BNP), although IL-11 has a certain value in predicting cardiac events. In addition, the CHF patients were divided into 3 groups according to the plasma IL-11 concentration category (low, T1; middle, T2; and high, T3). The multivariate Cox hazard analysis showed that the high plasma IL-11 concentrations were independently associated with the presence of cardiac events after adjustment for confounding factors. Furthermore, the CHF patients were divided into two groups based on the median plasma IL-11 concentrations. The Kaplan-Meier analysis revealed that the patients with high IL-11 concentrations had a higher risk of cardiac events compared with those with low IL-11 concentrations. Conclusions. Higher plasma IL-11 levels significantly increase the presence of cardiac events and suggest a poor outcome; although the diagnostic value of IL-11 in CHF is not as good as BNP, there is a certain value in predicting cardiac events in CHF.
format Article
id doaj-art-0c12b5699c334491be9a83f2a91ae595
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-0c12b5699c334491be9a83f2a91ae5952025-02-03T05:50:51ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/15754101575410Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart FailureJing Ye0Zhen Wang1Di Ye2Yuan Wang3Menglong Wang4Qingwei Ji5Ying Huang6Ling Liu7Ying Shi8Lei Shi9Tao Zeng10Yao Xu11Jianfang Liu12Huimin Jiang13Yingzhong Lin14Jun Wan15Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, ChinaBackground. Interleukin-11 (IL-11) is an important inflammatory cytokine and has been demonstrated to participate in cardiovascular diseases. However, there have been no studies about the role of IL-11 in heart failure (HF). The present study is aimed at investigating whether IL-11 levels are associated with the cardiac prognosis in patients with HF. Methods. The plasma concentrations of IL-11 were measured in 240 patients with chronic HF (CHF) and 80 control subjects without signs of significant heart disease. In addition, we prospectively followed these CHF patients to endpoints of cardiac events. Results. Compared with the control group, the plasma IL-11 concentrations were significantly increased in the CHF patients and gradually increased in the New York Heart Association (NYHA) functional class II group, the NYHA functional class III group, and the NYHA functional class IV group. The receiver operating characteristic (ROC) curve revealed that the predictive role of IL-11 in HF is not as good as N-terminal B-type natriuretic peptide (BNP), although IL-11 has a certain value in predicting cardiac events. In addition, the CHF patients were divided into 3 groups according to the plasma IL-11 concentration category (low, T1; middle, T2; and high, T3). The multivariate Cox hazard analysis showed that the high plasma IL-11 concentrations were independently associated with the presence of cardiac events after adjustment for confounding factors. Furthermore, the CHF patients were divided into two groups based on the median plasma IL-11 concentrations. The Kaplan-Meier analysis revealed that the patients with high IL-11 concentrations had a higher risk of cardiac events compared with those with low IL-11 concentrations. Conclusions. Higher plasma IL-11 levels significantly increase the presence of cardiac events and suggest a poor outcome; although the diagnostic value of IL-11 in CHF is not as good as BNP, there is a certain value in predicting cardiac events in CHF.http://dx.doi.org/10.1155/2019/1575410
spellingShingle Jing Ye
Zhen Wang
Di Ye
Yuan Wang
Menglong Wang
Qingwei Ji
Ying Huang
Ling Liu
Ying Shi
Lei Shi
Tao Zeng
Yao Xu
Jianfang Liu
Huimin Jiang
Yingzhong Lin
Jun Wan
Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
Mediators of Inflammation
title Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
title_full Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
title_fullStr Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
title_full_unstemmed Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
title_short Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
title_sort increased interleukin 11 levels are correlated with cardiac events in patients with chronic heart failure
url http://dx.doi.org/10.1155/2019/1575410
work_keys_str_mv AT jingye increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT zhenwang increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT diye increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT yuanwang increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT menglongwang increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT qingweiji increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT yinghuang increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT lingliu increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT yingshi increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT leishi increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT taozeng increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT yaoxu increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT jianfangliu increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT huiminjiang increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT yingzhonglin increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure
AT junwan increasedinterleukin11levelsarecorrelatedwithcardiaceventsinpatientswithchronicheartfailure